Page last updated: 2024-11-07

verticine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

verticine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131900
CHEBI ID9970
SCHEMBL ID336637
MeSH IDM0062608

Synonyms (41)

Synonym
5,14-cevanine-3,6,20-triol
cevane-3,6,20-triol, (3beta,5alpha,6alpha,25alpha)-
unii-34qdf8ufsy
(3beta,5alpha,6alpha)-cevane-3,6,20-triol
34qdf8ufsy ,
peimine
23496-41-5
verticine
zhebeinine
5alpha,14alpha,22beta-cevanine-3beta,6alpha,20beta-triol
wanpeinine-a
wanpeinine a
cevane-3,6,20-triol, (3beta,5alpha,6alpha,22beta)-
107299-20-7
S9281
AKOS025311477
SCHEMBL336637
CS-3731
CHEBI:9970
Q-100298
6.alpha.-dihydroisoimperialine
verticine [mi]
cevane-3,6,20-triol, (3.beta.,5.alpha.,6.alpha.)-
5.alpha.-cevane-3.beta.,6.alpha.,20-triol
HY-N0212
AC-7969
peimine, >=98% (hplc)
mfcd02259442
verticine (peimine)
(1r,2s,6s,9s,10s,11s,14s,15s,17s,18s,20s,23r,24s)-6,10,23-trimethyl-4-azahexacyclo[12.11.0.02,11.04,9.015,24.018,23]pentacosane-10,17,20-triol
BS-16581
peimine,(s)
Q27108541
cevane-3,6,20-triol, (3beta,5alpha,6alpha)-
CCG-269025
verticine;dihydroisoimperialine
(3s,4as,5s,6as,6bs,8as,9s,9as,12s,15as,15br,16as,16br)-9,12,16b-trimethyltetracosahydrobenzo[4,5]indeno[1,2-h]pyrido[1,2-b]isoquinoline-3,5,9-triol
dihydroisoimperialine
DTXSID70910283
cevane-3,6,20-triol
P2610

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The validated method was applied to the pharmacokinetic study of verticinone in rats after a single oral administration of 1 mg/kg."( Development and validation of a liquid chromatography-mass spectrometry method for the determination of verticinone in rat plasma and its application to pharmacokinetic study.
Chen, H; Liang, Y; Peng, Y; Sun, J; Wang, G; Wu, J; Wu, X; Zhang, P, 2010
)
0.36
" extract, the pharmacokinetic parameters were calculated as well."( [Simultaneous determination of peimine and peiminine in rat plasma by LC-MS/MS and its application in the pharmacokinetic study].
Chen, LH; Liu, HN; Liu, LL; Yi, WJ; Zhao, Y; Zhu, WF, 2010
)
0.36
"A sensitive LC-MS-MS method has been successfully applied to pharmacokinetic study of peimine and peiminine in rat plasma after oral administration of Fritillaria thunbergii Miq."( Comparative pharmacokinetic studies of peimine and peiminine in rat plasma by LC-MS-MS after oral administration of Fritillaria thunbergii Miq. and Fritillaria thunbergii Miq. - Glycyrrhiza uralensis Fisch. couple extract.
Chen, L; Liu, H; Liu, L; Yan, Z; Zhang, H; Zhu, W, 2011
)
0.37
"Compared with female rats, peimine and peiminine were eliminated slowly from male rat plasma, and significant gender-related differences were observed in the pharmacokinetic parameters."( Sex dependent pharmacokinetics, tissue distribution and excretion of peimine and peiminine in rats assessed by liquid chromatography-tandem mass spectrometry.
Chen, LH; Guan, YM; Guan, ZY; Liu, HN; Wang, S; Yi, WJ; Zhang, HM; Zhu, WF, 2013
)
0.39
"A simple LC-MS/MS method was developed for determination and pharmacokinetic study of peimine in beagle dogs."( A simple and sensitive LC-MS/MS method for quantitation of peimine and its pharmacokinetic in beagle dogs.
Liu, YY; Wang, W; Xu, J, 2013
)
0.39
" The analytical method was successfully applied to a pharmacokinetic study of the multi-components after oral administration of Sanjie Zhentong Capsule in rats."( Simultaneous determination of ten bioactive constituents of Sanjie Zhentong Capsule in rat plasma by ultra-high-performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.
Hu, JH; Huang, W; Li, D; Li, J; Pan, Y; Wang, Y; Wang, ZZ; Xiao, W, 2017
)
0.46

Bioavailability

ExcerptReferenceRelevance
" could decrease C(max) and prolong MRT(0-infinity) and t1/2 of peimine remarkly with the bioavailability of peimine remained practically unchanged."( Comparative pharmacokinetic studies of peimine and peiminine in rat plasma by LC-MS-MS after oral administration of Fritillaria thunbergii Miq. and Fritillaria thunbergii Miq. - Glycyrrhiza uralensis Fisch. couple extract.
Chen, L; Liu, H; Liu, L; Yan, Z; Zhang, H; Zhu, W, 2011
)
0.37
" Bitter almond and licorice can reduce the intestinal absorption rate ofpeimine and peiminine."( [Rat intestinal absorption trait of peimine and peiminine in Thunberg fritillary bulb extract].
Chen, LH; Guan, ZY; Liu, HN; Zhang, LH; Zhu, WF, 2013
)
0.39
" A significant gender difference in the pharmacokinetics of verticinone in rats was observed, as its absolute oral bioavailability in male and female rats was 45."( Pharmacokinetics, tissue distribution and excretion of verticinone from F. hupehensis in rats.
Chen, H; Liang, Y; Peng, Y; Sun, JG; Wang, GJ; Wu, JZ; Wu, X; Zhang, P, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
"In the present study, male BALB/c mice received an oral dosage of sodium carboxymethylcellulose (CMC-Na) (0."( Synergistic anti-inflammatory effects of peimine, peiminine, and forsythoside a combination on LPS-induced acute lung injury by inhibition of the IL-17-NF-κB/MAPK pathway activation.
Du, H; Gong, G; Liu, C; Ma, Q; Quan, ZS; Wu, Y; Zhen, D, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkaloidAny of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (8.20)18.7374
1990's4 (6.56)18.2507
2000's14 (22.95)29.6817
2010's27 (44.26)24.3611
2020's11 (18.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.52 (24.57)
Research Supply Index4.16 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]